SCREENING FOR INHERITED THYROID DEFECTS
筛查遗传性甲状腺缺陷
基本信息
- 批准号:7604798
- 负责人:
- 金额:$ 0.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2007-09-16
- 项目状态:已结题
- 来源:
- 关键词:Candidate Disease GeneCell LineChildClinical ResearchComputer Retrieval of Information on Scientific Projects DatabaseDNADefectFamilyFamily memberFundingGenesGrantHuman GeneticsInheritedInstitutionKnowledgeLaboratoriesMetabolismMolecularMutationOutcomeParentsPatientsPatternPhysiologyResearchResearch PersonnelResourcesScreening procedureSiblingsSourceStudy SubjectTestingThyroid DiseasesThyroid Function TestsThyroid GlandThyroid HormonesUnited StatesUnited States National Institutes of Healthbasegenetic linkage analysishormone regulationin vivoprograms
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The broad objectives of this study is to gain knowledge about the molecular mechanisms of thyroid physiology through the study of human genetic errors causing defects in thyroid hormone (TH) regulation, synthesis, transport, metabolism and action. Central to this program is the availability of patient material for clinical studies and laboratory support to identify the gene defects responsible for the in vivo observations. The study subjects are children identified to have congenital thyroid diseases and their immediate family members (parents and siblings). They are accessible through referrals from the United States and abroad. The GCRC laboratory performs DNA extractions and , when required, produces transformed lymphophast cell lines. The PI s laboratory performs thyroid function tests. Based on the pattern of these tests, candidate genes are identified and sequenced for the presence of mutations. In larger families, linkage analysis is carried out to identify genes potentially involved in the defects. The final outcome is identification of new gene defects causing congenital thyroid diseases.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
本研究的主要目的是通过研究导致甲状腺激素(TH)调节、合成、运输、代谢和作用缺陷的人类遗传错误,获得有关甲状腺生理学分子机制的知识。 该计划的核心是临床研究和实验室支持的患者材料的可用性,以确定负责体内观察的基因缺陷。 研究对象是被确定患有先天性甲状腺疾病的儿童及其直系亲属(父母和兄弟姐妹)。 他们可以通过美国和国外的转介获得。 GCRC实验室进行DNA提取,并在需要时产生转化的淋巴细胞系。 PI实验室进行甲状腺功能检查。 基于这些测试的模式,识别候选基因并对突变的存在进行测序。 在较大的家族中,进行连锁分析以确定可能涉及缺陷的基因。 最终的结果是鉴定出导致先天性甲状腺疾病的新基因缺陷。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Samuel Refetoff其他文献
Samuel Refetoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Samuel Refetoff', 18)}}的其他基金
THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERS
遗传性疾病的甲状腺生理学研究
- 批准号:
8049871 - 财政年份:2010
- 资助金额:
$ 0.08万 - 项目类别:
THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERS
遗传性疾病的甲状腺生理学研究
- 批准号:
7920503 - 财政年份:2009
- 资助金额:
$ 0.08万 - 项目类别:
Resistance and Hypersensitivity to Thyroid Hormone
对甲状腺激素的抵抗和过敏
- 批准号:
7040687 - 财政年份:2004
- 资助金额:
$ 0.08万 - 项目类别:
RESISTANCE & HYPERSENSITIVITY TO THYROID HORMONE--EFFECTS OF TRIIODOTHYRONINE
反抗
- 批准号:
6304541 - 财政年份:1999
- 资助金额:
$ 0.08万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 0.08万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 0.08万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 0.08万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 0.08万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 0.08万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 0.08万 - 项目类别:
Studentship